Skip to content


Aptiom, Zebinix (eslicarbazepine) is a small molecule pharmaceutical. Eslicarbazepine was first approved as Aptiom on 2009-04-21. It has been approved in Europe to treat epilepsy. Aptiom's patents are valid until 2032-08-24 (FDA).
Trade Name Zebinix
Common Name Eslicarbazepine
Indication epilepsy
Drug Class Tricyclic compounds
Get full access now